医药板块催化事件密集，近期新冠病例增长、三生制药拿下60亿出海大单、ASCO年会即将召开等助推行业热度，恒生医药ETF（159892）在连涨4日后小幅调整，盘中跌超1%。具体来看，三生制药在连续大涨后跌超4%，晶泰控股、荣昌生物、阿里健康等领跌。远大医药、诺诚健华、亚盛医药等逆势上涨。广发证券认为，中国创新药出海的全球竞争优势正在凸显。近年来，中国药企在海外市场的License-out交易实现了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.